All research
Healthcare

The GLP-1 Second Wave: What Consumer Health Missed

The first wave repriced pharma. The second wave is repricing everything adjacent to appetite, and consumer health names haven't caught up.

SW

Sam Whitfield

Analyst, Healthcare

June 14, 20266 min read

Overview

Reframing the second wave

The first wave of GLP-1 analysis focused correctly on pharma winners and packaged food losers. The second wave is quieter and harder to model: durable changes in portion size, snacking frequency, and alcohol consumption among a growing base of long-term users.

Categories with underappreciated exposure

Digestive health, vitamins, and portion-oriented meal categories show early volume shifts that are still being attributed to macro softness rather than to a structural change in the user base. We think this misattribution is creating a gap between market perception and underlying category dynamics worth watching closely.

GLP-1Consumer HealthBehavioral Shift

Disclaimer

This report is published for educational and informational purposes only. It is intended to help readers understand businesses, industries, and valuation frameworks, and does not constitute investment, legal, or tax advice, or a recommendation or solicitation to buy, sell, or hold any security. It does not include buy, sell, or hold ratings, price targets, expected returns, or personalized investment recommendations of any kind. Elevate Research is not a broker-dealer or registered investment adviser. The views expressed are those of the author as of the publication date and are subject to change without notice. Past performance is not indicative of future results. Readers should conduct their own due diligence and consult a licensed financial professional before making any investment decision.